Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis.
The efficacy of clarithromycin in a murine model of acute toxoplasmosis was studied. Clarithromycin was administered alone and concurrently with minocycline, and efficacy was assessed by survival rates and sequential determination of parasite burden in blood, brains, and lungs. Limited protection resulted from administration of each drug alone, whereas a remarkable synergistic effect followed concurrent administration. Survival of mice treated with 200 mg of clarithromycin plus 20 mg of minocycline per kg of body weight daily was 95%; that of mice treated with 50 mg of clarithromycin plus 50 mg of minocycline per kg daily was 93%. The parasite burden in the blood and organ tissues of these mice was markedly reduced compared with that in mice treated with a single agent. In mice treated with 200 mg of clarithromycin plus 50 mg of minocycline per kg per day, survival was 100% during the 30-day experiment; no parasites were found in blood and tissues.
Derouin
F
F
Laboratoire de Parasitologie-Mycologie, Hôpital Saint-Louis, Paris, France.
Caroff
B
B
Chau
F
F
Prokocimer
P
P
Pocidalo
J J
JJ
D000818:Animals; D017291:Clarithromycin / Q000627:therapeutic use*; D004357:Drug Synergism; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D051379:Mice; D008911:Minocycline / Q000627:therapeutic use*; D014124:Toxoplasmosis, Animal / Q000188:drug therapy* / Q000469:parasitology
D008911:Minocycline; D017291:Clarithromycin